|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical And Biotech Growth Strategies: Future Drivers And Opportunities
Business Insights, Jan 2004, Pages: 150
Where are the pharma and biotech sectors heading in 2004 and beyond...? The management report ‘Future Growth Strategies: Drivers of sustainable development within the biotech, specialty and major pharma sectors’, provides the timely analysis senior executives need to maximize business opportunities in 2004. This report assesses favored growth strategies for pharma and biotechs and offers productive solutions to assure long-term success. This report examines the feasibility of blockbuster drug development as a foundation of major pharma growth and proposes alternatives to expansion through M&A, expounding the benefits of in-licensing and then networked growth. It also focuses on the group of small ethical, generics, drug delivery and certain biotech firms that together constitute the specialty pharma sector. Fundamentally this report will provide you with the analysis you need to; grow in your own sector successfully, understand other sectors’ growth strategies, take advantage of new market opportunities and prepare counter strategies for threats presented by new entrants.
Customers who bought this item also bought
Impact of Pharmacogenomics on Public Healthcare Policy: Educating Patients, Payors and Healthcare Providers
Personalized Medicine 2010
The Specialty Pharma Market Outlook: Key Players, New Company Growth Models and Emerging Opportunities
Innovations in Diagnostics: Next Generation Molecular and Point-of-Care Diagnostics Driving Personalized Healthcare
Personalized Medicine Market Worldwide (2010 – 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast
Pulmonary Inhalers & Systemic Drug Delivery: Devices, Drugs, Therapeutics, Market Factors & Forecasts
Molecular Diagnostics - Technologies, Markets and Companies
Antiageing and Life Enhancement Pharmacotherapeutics: Rejuvenating Drug Markets To 2012 and Beyond
Companion Diagnostics in Personalized Medicine and Cancer Therapy
Molecular Diagnostics Markets
|
|
|
|
